Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I'm down about 50% from my average here atm. Unless I actually see more of the same dilution behavior from the past in the next 10-Q, I'm holding this through the summer. The renegotiation of debt last month tells me that they are actually trying to mitigate the effect of the notes. The FDA approval for Epidiolex (https://www.gwpharm.com/epilepsy-patients-caregivers/patients) this summer will likely send this company through the roof as long as they keep building out the business at this pace. The practitioner side of the business will go gangbusters as long as they prepare before the summer. I saw the numerous posts they had posted for sales positions across the nation when the company first announced the acquisition. The next 10-Q should reflect all of these things, but we'll have to wait and see. I've been on this board since last Sep, so I'll try to put together a DD post this weekend with all of the details going back to then. It's a LOT.
That still doesn’t make sense. If you really wanted others to stay away, you would have already sold your own shares. If you really are in and you’re not looking to load more, all I can say is good luck with your investment pursuits.
That logic doesn’t make sense. You’re helping your competition by scaring people into selling by warning of a RS that doesn’t exist. Sorry you’re down mate.
Totally agree with that. People wouldn't spend their time on here talking about how much this company is a piece of garbage if they didn't have their own motives. A lot of scare tactics going on, and I guarantee they will stop or people will change their tune when the price stabilizes, aka their bids gets filled. This cycle has been going on for months, and if you go back through the board history, you'll see the various players and their changes of heart. The noise to info ratio on this board has gotten so high recently though.
Saying that you must be wealthy to be a CEO is ridiculous. You can inherit a ton of money and be a terrible CEO. A great CEO makes plans to steer the company and executes them. Focusing on profitability is key here. This CEO is building the company and setting up for the long run. You can see that through the new vendors popping up on cbd.co every week. They will be well-positioned for catalysts happening later this year. These notes are bumps in the road in the long run. Sure, they’re big bumps, but sit back and take advantage of the opportunities.
Over 17k of that note was paid back in Nov. What makes you think they haven’t paid more down since then?
The minor dilution today was likely one of the noteholders trying to take advantage of the last few days they can convert against the low of .0027. Assuming the price doesn’t drop that low again, they’ll be converting at higher prices in a few days and would be remiss to sell lower lest they let those juicy profits slip away.
Some real scare tactics going on atm
That’s a great point, have you suggested this strategy to GRCK management? I’m sure Patrick would love to hear about it.
That’s also the reason the new CEO and his partner got the lion’s share of the common and preferred shares out of the Eqova deal. He’s bringing the company out of the path they were headed and into profitability.
They spent the money on the business. Before the Eqova acquisition, they weren’t bringing in enough money to cover the costs to stay open, so they were financing to stay afloat for a few years. The Eqova acquisition formed an entirely new company with a new CEO at the helm. Investing in the company right now means investing in the new CEO and his vision for the new company. I’ve done a ton of DD on this guy including a background check and research on his past (and current) ventures. I’ve also had multiple conversations with him. He’s a rare leader that actually responds when I reach out to him. He’s the real deal.
A healthy amount of skepticism is good, but dang dude. You haven’t expressed one positive thing about the company lol. Why would you invest in something that you think is broken?
Have you given them any shareholders money? With all the skepticism, I’m not sure why you would want to invest in the company? You’re looking for a perfect company with a perfect product? Are there any of those?
It sounds like you might flourish in a career in QA? Are you sending these bugs to the company? They would get greater benefit from these reports than the IH board?
What are your thoughts on this?
They are left over from the period prior to the Eqova acquisition. The new CEO since the acquisition stated that paying off the debts and becoming profitable is his priority. They paid off a lot of it in the last 10-Q, and a lot since, though we don’t know the total settled yet. Also they renegotiated one of the upcoming notes with more favorable terms last month. The next 10-Q will be telling whether he means to stop the note cycle or not. The way they are setting up the traffic funnels with the youtube channel and learning center on cbd.co is the right way to grow an online business through organic traffic.
Did anyone else notice that they accept Bitcoin and Litecoin on cbd.co?!?!?! Did I miss that memo? I haven't seen it advertised anywhere, but it shows up as accepted payment methods at the bottom of the homepage: https://cbd.co" rel="nofollow" target="_blank" >https://cbd.co!
Here is my prior post on this issue: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=136463488. It includes a link to the OTCQB rules doc and snippets taken. Basically this isn't a problem yet. It's definitely an ongoing concern until we get back over .01, but GRCK is not in danger of being downgraded atm.
Ok I’ll bite. This is simple supply and demand economics. For the company to omit a product solely on the idea that it is cost-prohibitive to a portion of their customers would be putting their heads in the sand. If the product doesn’t sell, they always have the ability to take it down. Having it there in the first place does no harm at all. Additionally, high-priced items catch eyeballs, increasing traffic as people share the link, as was already done on this very board simply because of the price. Free neutral exposure is always a good thing.
Ah ok, thanks. Glad they have that relationship established.
Considering the manufacturer sells it for the same price, it really is the best deal on this particular product: http://www.purehempnoticsshop.com/product-p/ph-n1.htm. Go ahead, keep reaching for ways to scare investors on the board, but you’re really stretching to find them now, and I think that’s blatantly obvious.
Just noticed that Elixinol has products on cbd.co now: https://cbd.co/seller/elixinol/. Not sure if that’s new or I missed it at launch.
Please stop this. You’re comparing an aged mature apple orchard to a sapling. In week 2 of launching amazon.com, I highly doubt they were adding new release books on a daily basis. This company will grow into an apple tree this year, and more seeds are being planted. When we start seeing the 10-Qs of this new company, we’ll start seeing the fruit. Stop trying to sell your rotten fruit on here and just buy your shares when you feel comfortable.
Hey look at this, I am ALSO buying cbd.co. But I undercut you by $1,000, so I'm pretty sure I'll get it.
Fake CBD Escrow Transaction
Get your fake stuff out of here man. People try to scare new investors out of their shares on here all the time, but creating a fake document is a new low on this board. You have discredited all of your posts, and I would advise the moderators of the board to ban highlandernew.
These are my thoughts about this.
Something of interest to note from today’s trading: There were 1M+ bids at .0058 and .0063 that did not get filled. Not even a T-trade. Note holders still have the opportunity to sell shares at their discounted rate of the lowest price in the past 20 days, .0027. With the discount, their price would be close to .0010. Anyone in their right mind would have sold into that 1M bid at .0063 unless they 1) don’t have the shares to sell, or 2) know this is going up in the near future. Those .0027 prices are only available to them for a few more days, so that tells me they are in no real hurry to sell.
Part of the Jan note was already paid in the last 10-Q on Sep 30. I imagine more of it was paid since then. Hard to say how it will affect trading, but if we get over .01, I don’t think the notes will be much of a problem moving forward. I also imagine the noteholders who could take advantage of the low .0027 price already did, and won’t be providing much resistance in the near term.
Lol, this is how you build a successful business online. You create a product. You generate a healthy amount of helpful content. You direct people to the content. You become the authority on the subject. People come to you to buy your stuff. People recommend you to others. You can disagree, but anyone on here who has done it can attest to this.
Looks like CBD.co tweeted addressing the Ganjapreneur listing cbd.co for sale: https://twitter.com/CbdDotco/status/950251414495756288.
I notified the CEO directly on Wed this week about the .com contact email and he acknowledged it needed to be fixed. Not sure what’s taking so long to fix it.
Power hour today could be telling. If the bids start getting slaughtered, then we're heading lower. If not, this could be confirmation of a trend change. Still hard to tell, so I'm not buying more just yet.
We’ve seen this a few times over the past months. May see one tomorrow with this update.
230 M OS? Not friggin bad! I expected closer to 300 M. Still some to go on debt, but as KIR pointed out, volume will shred them if the company can generate it with updates.
I haven’t gotten a reply to my earlier message yet, but I plan on segueing into numbers and if they plan on posting any.
I agree on that, a pretty dull and ineffective tweet. I would venture to guess that Patrick is starting to focus back on the practitioner portion of Eqova, and letting the new CMO handle the cbd.co marketing. I sent him a message this morning, I’ll bring it up when he responds.
This will likely need to go down to test yesterday’s low / prior resistance at .0043 before it can go back up at this point. Hopefully it will base there and start making a comeback to test .01 next week.
Better yet, talk with him. Send him an email, he normally responds within the day. He's very sharp, and you can tell that he can build this company into a monster.
I'd agree with that. It will need to find a base before it goes up again. I'm encouraged by the lack of a T-trade today, but it doesn't mean dilution is over yet.
Many traders on here, and only a handful of investors. Once they give an update on debt and release the SS and ppl see that the OS is not that bad, this thing will move to more reasonable levels. Until then, take advantage of the dips like today and maybe tomorrow.
It still does really. There are so many MJ and CBD catalysts this year that Eqova will be well-positioned for. I'll be loading a ton more tomorrow if it dips more around .004. This day-to-day trading doesn't matter much if you have the long-game in mind.
One of the noteholders has warrants at 0.50 as well. I doubt they have been exercised since the stock has not been over .50 since the day that note was executed.
So many ppl on here trying to take advantage of people's emotions to get in at a lower price. Although it's annoying, they wouldn't do it if it didn't work. They'll be cheerleaders again as soon as they buy in again lol.